201 related articles for article (PubMed ID: 33469668)
1. Biological Effective Dose as a Predictor of Hypopituitarism After Single-Fraction Pituitary Adenoma Radiosurgery: Dosimetric Analysis and Cohort Study of Patients Treated Using Contemporary Techniques.
Graffeo CS; Perry A; Link MJ; Brown PD; Young WF; Pollock BE
Neurosurgery; 2021 Mar; 88(4):E330-E335. PubMed ID: 33469668
[TBL] [Abstract][Full Text] [Related]
2. Hypopituitarism After Single-Fraction Pituitary Adenoma Radiosurgery: Dosimetric Analysis Based on Patients Treated Using Contemporary Techniques.
Graffeo CS; Link MJ; Brown PD; Young WF; Pollock BE
Int J Radiat Oncol Biol Phys; 2018 Jul; 101(3):618-623. PubMed ID: 29678524
[TBL] [Abstract][Full Text] [Related]
3. Dose to neuroanatomical structures surrounding pituitary adenomas and the effect of stereotactic radiosurgery on neuroendocrine function: an international multicenter study.
Pomeraniec IJ; Xu Z; Lee CC; Yang HC; Chytka T; Liscak R; Martinez-Alvarez R; Martinez-Moreno N; Attuati L; Picozzi P; Kondziolka D; Mureb M; Bernstein K; Mathieu D; Maillet M; Ogino A; Long H; Kano H; Lunsford LD; Zacharia BE; Mau C; Tuanquin LC; Cifarelli C; Arsanious D; Hack J; Warnick RE; Strickland BA; Zada G; Chang EL; Speckter H; Patel S; Ding D; Sheehan D; Sheehan K; Kvint S; Buch LY; Haber AR; Shteinhart J; Vance ML; Sheehan JP
J Neurosurg; 2022 Mar; 136(3):813-821. PubMed ID: 34560630
[TBL] [Abstract][Full Text] [Related]
4. The Impact of Insulin-Like Growth Factor Index and Biologically Effective Dose on Outcomes After Stereotactic Radiosurgery for Acromegaly: Cohort Study.
Graffeo CS; Donegan D; Erickson D; Brown PD; Perry A; Link MJ; Young WF; Pollock BE
Neurosurgery; 2020 Sep; 87(3):538-546. PubMed ID: 32267504
[TBL] [Abstract][Full Text] [Related]
5. Hypopituitarism after stereotactic radiosurgery for pituitary adenomas.
Xu Z; Lee Vance M; Schlesinger D; Sheehan JP
Neurosurgery; 2013 Apr; 72(4):630-7; 636-7. PubMed ID: 23277375
[TBL] [Abstract][Full Text] [Related]
6. Effect of distance from target on hypopituitarism after stereotactic radiosurgery for pituitary adenomas.
Ironside N; Snyder H; Xu Z; Schlesinger D; Chen CJ; Vance ML; Hong GK; Jane JA; Sheehan JP
J Neurooncol; 2022 May; 158(1):41-50. PubMed ID: 35461378
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with endocrine deficits after stereotactic radiosurgery of pituitary adenomas.
Leenstra JL; Tanaka S; Kline RW; Brown PD; Link MJ; Nippoldt TB; Young WF; Pollock BE
Neurosurgery; 2010 Jul; 67(1):27-32; discussion 32-3. PubMed ID: 20559089
[TBL] [Abstract][Full Text] [Related]
8. Role of biological effective dose for prediction of endocrine remission in acromegaly patients treated with stereotactic radiosurgery.
Dumot C; Schlesinger D; Mantziaris G; Dayawansa S; Xu Z; Sheehan JP
Pituitary; 2023 Feb; 26(1):124-131. PubMed ID: 36471108
[TBL] [Abstract][Full Text] [Related]
9. The efficacy of fractionated radiotherapy and stereotactic radiosurgery for pituitary adenomas: long-term results of 125 consecutive patients treated in a single institution.
Kong DS; Lee JI; Lim DH; Kim KW; Shin HJ; Nam DH; Park K; Kim JH
Cancer; 2007 Aug; 110(4):854-60. PubMed ID: 17599761
[TBL] [Abstract][Full Text] [Related]
10. Hypopituitarism after Gamma Knife surgery for postoperative nonfunctioning pituitary adenoma.
Oh JW; Sung KS; Moon JH; Kim EH; Chang WS; Jung HH; Chang JW; Park YG; Kim SH; Chang JH
J Neurosurg; 2018 Dec; 129(Suppl1):47-54. PubMed ID: 30544293
[TBL] [Abstract][Full Text] [Related]
11. Stereotactic Radiosurgery for Residual and Recurrent Nonfunctioning Pituitary Adenomas: A Contemporary Case Series of GammaKnife and CyberKnife Radiosurgery.
Tucker D; Penn M; Brunswick A; Uttarwar V; Gogia A; Marietta M; Yu C; Carmichael J; Chang E; Zada G
World Neurosurg; 2020 Nov; 143():e60-e69. PubMed ID: 32603864
[TBL] [Abstract][Full Text] [Related]
12. Effects of Neuroanatomic Structural Distances on Pituitary Function After Stereotactic Radiosurgery: A Multicenter Study.
Ironside N; Chen CJ; Xu Z; Schlesinger D; Lee Vance M; Hong GK; Jane JA; Patel S; Bindal SK; Niranjan A; Lunsford LD; Liscak R; Chytka T; Jezkova J; Saifi O; Trifiletti DM; Berger A; Alzate J; Bernstein K; Kondziolka D; Speckter H; Hernandez W; Lazo E; Peker S; Samanci Y; Zacharia BE; Mau C; Wegner RE; Shepard MJ; Mathieu D; Maillet M; Sheehan JP
Neurosurgery; 2023 May; 92(5):1035-1042. PubMed ID: 36700741
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of higher dose stereotactic radiosurgery for functional pituitary adenomas: a preliminary report.
Grant RA; Whicker M; Lleva R; Knisely JP; Inzucchi SE; Chiang VL
World Neurosurg; 2014; 82(1-2):195-201. PubMed ID: 23385448
[TBL] [Abstract][Full Text] [Related]
14. Hypopituitarism after gamma knife radiosurgery for pituitary adenoma.
Zibar Tomšić K; Dušek T; Kraljević I; Heinrich Z; Solak M; Vučinović A; Ozretić D; Mihailović Marasanov S; Hršak H; Kaštelan D
Endocr Res; 2017 Nov; 42(4):318-324. PubMed ID: 28537768
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic radiosurgery for non-functioning pituitary adenomas: meta-analysis and International Stereotactic Radiosurgery Society practice opinion.
Kotecha R; Sahgal A; Rubens M; De Salles A; Fariselli L; Pollock BE; Levivier M; Ma L; Paddick I; Regis J; Sheehan J; Yomo S; Suh JH
Neuro Oncol; 2020 Mar; 22(3):318-332. PubMed ID: 31790121
[TBL] [Abstract][Full Text] [Related]
16. Stereotactic Radiosurgery for Acromegaly: An International Multicenter Retrospective Cohort Study.
Ding D; Mehta GU; Patibandla MR; Lee CC; Liscak R; Kano H; Pai FY; Kosak M; Sisterson ND; Martinez-Alvarez R; Martinez-Moreno N; Mathieu D; Grills IS; Blas K; Lee K; Cifarelli CP; Katsevman GA; Lee JYK; McShane B; Kondziolka D; Lunsford LD; Vance ML; Sheehan JP
Neurosurgery; 2019 Mar; 84(3):717-725. PubMed ID: 29757421
[TBL] [Abstract][Full Text] [Related]
17. Gamma Knife radiosurgery for acromegaly: Evaluating the role of the biological effective dose associated with endocrine remission in a series of 42 consecutive cases.
Balossier A; Tuleasca C; Cortet-Rudelli C; Soto-Ares G; Levivier M; Assaker R; Reyns N
Clin Endocrinol (Oxf); 2021 Mar; 94(3):424-433. PubMed ID: 32984972
[TBL] [Abstract][Full Text] [Related]
18. Target delineation and optimal radiosurgical dose for pituitary tumors.
Minniti G; Osti MF; Niyazi M
Radiat Oncol; 2016 Oct; 11(1):135. PubMed ID: 27729088
[TBL] [Abstract][Full Text] [Related]
19. Gamma Knife radiosurgery for the management of nonfunctioning pituitary adenomas: a multicenter study.
Sheehan JP; Starke RM; Mathieu D; Young B; Sneed PK; Chiang VL; Lee JY; Kano H; Park KJ; Niranjan A; Kondziolka D; Barnett GH; Rush S; Golfinos JG; Lunsford LD
J Neurosurg; 2013 Aug; 119(2):446-56. PubMed ID: 23621595
[TBL] [Abstract][Full Text] [Related]
20. Gamma Knife surgery for patients with nonfunctioning pituitary macroadenomas: predictors of tumor control, neurological deficits, and hypopituitarism.
Starke RM; Williams BJ; Jane JA; Sheehan JP
J Neurosurg; 2012 Jul; 117(1):129-35. PubMed ID: 22577749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
